Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources

Breast Cancer Research and Treatment

Volumn 157, Issue 3, 2016, Pages 575-586

  Akinyemiju, Tomi ^a   Moore, Justin Xavier ^a   Ojesina, Akinyemi I ^a,b   Waterbor, John W ^a   Altekruse, Sean F ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer outcomes; Healthcare access; Hormone receptor subtype; Racial disparities; Socio economic status

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BLACK PERSON; BREAST CANCER; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; ETHNICITY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DISPARITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; RACISM; SOCIAL STATUS; SURVIVAL RATE; AFRICAN AMERICAN; BREAST TUMOR; CANCER REGISTRY; ETHNOLOGY; HEALTH DISPARITY; HEALTH EQUITY; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; SOCIOECONOMICS; VERY ELDERLY;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH EQUITY; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SEER PROGRAM; SOCIOECONOMIC FACTORS;

EID: 84973118016     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-016-3840-x     Document Type: Article

References (38)

1. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2015) SEER cancer statistics review, 1975–2012. Vol based on Nov 2014 SEER data submission. National Cancer Institute, Bethesda
2. McCarthy AM, Yang J, Armstrong K (2015) Increasing disparities in breast cancer mortality from 1979 to 2010 for US black women aged 20 to 49 years. Am J Public Health 105(Suppl 3):S446–S448. doi:10.2105/AJPH.2014.302297
3. Aizer AA, Wilhite TJ, Chen MH, Graham PL, Choueiri TK, Hoffman KE, Martin NE, Trinh QD, Hu JC, Nguyen PL (2014) Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer 120(10):1532–1539. doi:10.1002/cncr.28617
4. Akinyemiju TF, Soliman AS, Johnson NJ, Altekruse SF, Welch K, Banerjee M, Schwartz K, Merajver S (2013) Individual and neighborhood socioeconomic status and healthcare resources in relation to black–white breast cancer survival disparities. J Cancer Epidemiol 2013:490472. doi:10.1155/2013/490472
5. Jadav S, Rajan SS, Abughosh S, Sansgiry SS (2015) The role of socioeconomic status and health care access in breast cancer screening compliance among hispanics. J Public Health Manag Pract 21(5):467–476. doi:10.1097/PHH.0000000000000235
6. Sheppard VB, Oppong BA, Hampton R, Snead F, Horton S, Hirpa F, Brathwaite EJ, Makambi K, Onyewu S, Boisvert M, Willey S (2015) Disparities in breast cancer surgery delay: the lingering effect of race. Ann Surg Oncol 22(9):2902–2911. doi:10.1245/s10434-015-4397-3
7. Akinyemiju TF, Vin-Raviv N, Chavez-Yenter D, Zhao X, Budhwani H (2015) Race/ethnicity and socio-economic differences in breast cancer surgery outcomes. Cancer Epidemiol 39(5):745–751. doi:10.1016/j.canep.2015.07.010
8. Tao L, Gomez SL, Keegan TH, Kurian AW, Clarke CA (2015) Breast cancer mortality in African-American and non-hispanic white women by molecular subtype and stage at diagnosis: a population-based study. Cancer Epidemiol Biomarkers Prev 24(7):1039–1045. doi:10.1158/1055-9965.EPI-15-0243
9. Parise CA, Caggiano V (2015) The influence of socioeconomic status on racial/ethnic disparities among the ER/PR/HER2 breast cancer subtypes. J Cancer Epidemiol 2015:813456. doi:10.1155/2015/813456
10. Akinyemiju T, Moore JX, Altekruse SF (2015) Breast cancer survival in African-American women by hormone receptor subtypes. Breast Cancer Res Treat. doi:10.1007/s10549-015-3528-7
11. Boyle P (2012) Triple-negative breast cancer: epidemiological considerations and recommendations. Ann Oncol. doi:10.1093/annonc/mds187
12. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2011) AJCC cancer staging manual, 7th edn. American Joint Committee on Cancer, Chicago, IL
13. Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LAG, Cronin KA (2014) US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst 106(5):1–8. doi:10.1093/jnci/dju055
14. Ihemelandu CU, Leffall LD, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA (2007) Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival. J Surg Res 143:109–118. doi:10.1016/j.jss.2007.03.085
15. Ihemelandu CU, Naab TJ, Mezghebe HM, Makambi KH, Siram SM, Leffall LD, DeWitty RL, Frederick WA (2008) Basal cell-like (triple-negative) breast cancer, a predictor of distant metastasis in African American women. Am J Surg 195:153–158. doi:10.1016/j.amjsurg.2007.09.033
16. Newman L (2014) Breast cancer disparities: high-risk breast cancer and African ancestry. Surg Oncol Clin N Am 23:579–592
17. Parise CA, Caggiano V (2014) Breast cancer survival defined by the ER/PR/HER2 subtypes and a surrogate classification according to tumor grade and immunohistochemical biomarkers. J Cancer Epidemiol 2014:11. doi:10.1155/2014/469251
18. Akinyemiju TF, Pisu M, Waterbor JW, Altekruse SF (2015) Socioeconomic status and incidence of breast cancer by hormone receptor subtype. Springer 4:508. doi:10.1186/s40064-015-1282-2
19. Feinglass J, Rydzewski N, Yang A (2015) The socioeconomic gradient in all-cause mortality for women with breast cancer: findings from the 1998 to 2006 national cancer data base with follow-up through 2011. Ann Epidemiol 25(8):549–555. doi:10.1016/j.annepidem.2015.02.006
20. Kish JK, Yu M, Percy-Laurry A (2014) Altekruse SF (2014) Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in Surveillance, Epidemiology, and End Results (SEER) registries. J Natl Cancer Inst Monogr 49:236–243. doi:10.1093/jncimonographs/lgu020
21. Parise CA, Caggiano V (2013) Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000–2010. BMC Cancer 13:449. doi:10.1186/1471-2407-13-449
22. Silber JH, Rosenbaum PR, Clark AS, Giantonio BJ, Ross RN, Teng Y, Wang M, Niknam BA, Ludwig JM, Wang W, Even-Shoshan O, Fox KR (2013) Characteristics associated with differences in survival among black and white women with breast cancer. JAMA 310(4):389–397. doi:10.1001/jama.2013.8272
23. Shariff-Marco S, Yang J, John EM, Kurian AW, Cheng I, Leung R, Koo J, Monroe KR, Henderson BE, Bernstein L, Lu Y, Kwan ML, Sposto R, Vigen CL, Wu AH, Keegan TH, Gomez SL (2015) Intersection of race/ethnicity and socioeconomic status in mortality after breast cancer. J Community Health 40(6):1287–1299. doi:10.1007/s10900-015-0052-y
24. Roseland ME, Pressler ME, Lamerato LE, Krajenta R, Ruterbusch JJ, Booza JC, Schwartz K, Simon MS (2015) Racial differences in breast cancer survival in a large urban integrated health system. Cancer 121(20):3668–3675. doi:10.1002/cncr.29523
25. Akinyemiju TF, Soliman AS, Yassine M, Banerjee M, Schwartz K, Merajver S (2012) Healthcare access and mammography screening in Michigan: a multilevel cross-sectional study. Int J Equity Health 11:16. doi:10.1186/1475-9276-11-16
26. Fan JX, Hanson HA, Zick CD, Brown BB, Kowaleski-Jones L, Smith KR (2014) Geographic scale matters in detecting the relationship between neighbourhood food environments and obesity risk: an analysis of driver license records in Salt Lake County, Utah. BMJ Open 4(8):e005458. doi:10.1136/bmjopen-2014-005458
27. Subramanian SV, Chen JT, Rehkopf DH, Waterman PD, Krieger N (2006) Comparing individual- and area-based socioeconomic measures for the surveillance of health disparities: a multilevel analysis of Massachusetts births, 1989–1991. Am J Epidemiol 164(9):823–834. doi:10.1093/aje/kwj313
28. Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV (2003) Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures—the public health disparities geocoding project. Am J Public Health 93(10):1655–1671
29. Diez Roux AV (2002) A glossary for multilevel analysis. J Epidemiol Community Health 56(8):588–594
30. Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LA, Cronin KA (2014) US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst 106(5):1–8. doi:10.1093/jnci/dju055
31. Joslin CE, Brewer KC, Davis FG, Hoskins K, Peterson CE, Pauls HA (2014) The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago. Gynecol Oncol 135(2):285–291. doi:10.1016/j.ygyno.2014.08.029
32. Bristow RE, Powell MA, Al-Hammadi N, Chen L, Miller JP, Roland PY, Mutch DG, Cliby WA (2013) Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst 105(11):823–832. doi:10.1093/jnci/djt065
33. Gomez DR, Liao KP, Giordano S, Nguyen H, Smith BD, Elting LS (2013) Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer: a population-based study. Cancer 119(7):1428–1436. doi:10.1002/cncr.27899
34. Devoe JE, Baez A, Angier H, Krois L, Edlund C, Carney PA (2007) Insurance + access not equal to health care: typology of barriers to health care access for low-income families. Ann Fam Med 5(6):511–518. doi:10.1370/afm.748
35. Bristow RE, Chang J, Ziogas A, Campos B, Chavez LR, Anton-Culver H (2015) Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines. Obstet Gynecol 125(4):833–842. doi:10.1097/AOG.0000000000000643
36. Hines RB, Barrett A, Twumasi-Ankrah P, Broccoli D, Engelman KK, Baranda J, Ablah EA, Jacobson L, Redmond M, Tu W, Collins TC (2015) Predictors of guideline treatment nonadherence and the impact on survival in patients with colorectal cancer. J Natl Compr Cancer Netw 13(1):51–60
37. Bristow RE, Chang J, Ziogas A, Anton-Culver H, Vieira VM (2014) Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status. Gynecol Oncol 134(1):60–67. doi:10.1016/j.ygyno.2014.03.561
38. Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? The public health disparities geocoding project. Am J Epidemiol 156(5):471–482